Have you ever considered an acquisition? How about timing the launch of a new technology? Rick Anderson who has a deep background in the M & A world and as a President and General Manager launching new technologies at DarioHealth walks us through the key elements of growth strategies. Rick provides this information in a […]

Several biotech executives provided their thoughts on lessons learned from the pandemic and what they hope or expect to see moving forward in the industry. Although the COVID-19 pandemic is still raging in parts of the world, such as India, it is fading in the U.S. and much of Europe. The biopharma industry has been at the […]

DocWire News recently spoke with Dr. Jim Woody, CEO of 180 Life Sciences, a company that develops new treatments for inflammation. Dr. Woody and his team have now fully enrolled phase 2/3 study for the treatment of Dupuytren’s contracture. See what he had to say.